Senthilkumar Sadhasivam

Dr. Sadhasivam is a physician-scientist-entrepreneur who formed OpalGenix to translate findings from his long career in perioperative research focused on opioid pharmacogenetics and pharmacokinetics, combinatorial pharmacogenetic decision algorithms, and proactive prediction of opioid adverse effects, including respiratory depression and opioid dependence. Dr. Sadhasivam is currently the Vice-Chair of Research, Department of Anesthesia, IUSM; and Gopal Krishna Endowed and Tenured Professor of Pediatric Anesthesia at Riley Hospital for Children. Based on efforts over more than 12 years, Dr. Sadhasivam and his team have established reliable and robust multi-genetic signatures for predicting high risk for adverse opioid adverse outcomes. With an MPH from Harvard’s School of Public Health (Public Health & Clinical Effectiveness) and an MBA (Business of Medicine) from the IU Kelley School of Business, Dr. Sadhasivam is well-positioned to translate these exciting discoveries into the clinic.